The treatment of Cushing's syndrome was addressed recently by guidelines developed by the Endocrine Society. These indicate that the optimal treatment, when possible, is surgical resection of the causative tumor(s). When this is not possible, or the patient recurs, secondary treatment in Cushing's disease involves radiation therapy with adjunctive use of cortisol-lowering medications, or tumor-directed medical therapy such as cabergoline, or pasireotide or glucocorticoid receptor-directed treatment with mifepristone. Patients with ectopic ACTH secretion may have an occult or widely metastatic tumor, neither of which is amenable to surgical treatment. In this case, medical therapy with cortisol -lowering medications or mifepristone, or bilateral adrenalectomy, may be chosen. Treatments should be individualized to the circumstances, presentation, goals and values of each patient. Co-morbidities should be addressed in addition to primary tumor-directed therapy.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
Zip Code
Feelders, Richard A; Newell-Price, John; Pivonello, Rosario et al. (2018) Advances in the medical treatment of Cushing's syndrome. Lancet Diabetes Endocrinol :
Nieman, Lynnette Kaye (2018) Diagnosis of Cushing's Syndrome in the Modern Era. Endocrinol Metab Clin North Am 47:259-273
Chatain, Grégoire P; Patronas, Nicholas; Smirniotopoulos, James G et al. (2018) Potential utility of FLAIR in MRI-negative Cushing's disease. J Neurosurg 129:620-628
Ironside, Natasha; Chatain, Gregoire; Asuzu, David et al. (2018) Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease. Eur J Endocrinol 178:255-263
Nieman, Lynnette K (2018) Recent Updates on the Diagnosis and Management of Cushing's Syndrome. Endocrinol Metab (Seoul) 33:139-146
Asuzu, David; Chatain, Grégoire P; Hayes, Christina et al. (2017) Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease. J Clin Endocrinol Metab 102:2179-2187
Del Rivero, Jaydira; Kim, Chul; Eid, Mary et al. (2017) Thymic Hyperplasia after Treatment of ACTH-Dependent Cushing's Syndrome Can Be Mistaken for a Thymic Epithelial Tumor. J Thorac Oncol 12:e29-e32
Lonser, Russell R; Nieman, Lynnette; Oldfield, Edward H (2016) Cushing's disease: pathobiology, diagnosis, and management. J Neurosurg :1-14
Sharma, S T; Nieman, L K; Feelders, R A (2015) Comorbidities in Cushing's disease. Pituitary 18:188-94
Nieman, Lynnette K; Biller, Beverly M K; Findling, James W et al. (2015) Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100:2807-31

Showing the most recent 10 out of 14 publications